Western blotting showed that the relative expression levels of p-IκBα and p-P38 MAPK were significantly lower in the AD + BM25-M (p-IκBα: 0.353 ± 0.012; p-p38 : 0.152 ± 0.022) and AD + BM25-H groups (p-IκBα: 0.229 ± 0.015; p-p38 : 0.109 ± 0.019) than in the AD + NS group (p-IκBα: 0.758 ± 0.021; p-p38 : 0.577 ± 0.024) (p < 0.05). This evidence concerns the gene NFKBIA and Alzheimer disease.